Clinical Trial Update: A Study of NB003 in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study of NB003 in patients with advanced solid tumors has completed enrollment and is marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• NB003

Snippet

Sponsor: Ningbo Newbay Technology Development Co., Ltd | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED